XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities:    
Net income $ 90,800 $ 194,281
Adjustments to reconcile net income to net cash provided by operating activities:    
Net amortization/accretion of premium/discount on securities 16,092 9,029
Depreciation, amortization and accretion 21,031 2,276
Provision for credit losses 168,221 14,379
Gain on mortgage loans sold, net (28,202) (10,889)
Investment losses (gains) on sales, net (335) 6,426
Stock-based compensation expense 9,649 10,073
Deferred tax expense (benefit) (24,038) 6,907
Losses on dispositions of other real estate and other investments 5,033 2,438
Income from equity method investment (32,800) (45,551)
Dividends received from equity method investment 7,957 40,914
Excess tax benefit from stock compensation (590) (701)
Gain on commercial loans sold, net (1,221) (1,809)
Increase in other assets (173,328) (50,505)
Increase in other liabilities 83,745 35,230
Net cash provided by operating activities 185,198 184,045
Activities in securities available-for-sale:    
Purchases (810,119) (670,956)
Sales 100,055 476,702
Maturities, prepayments and calls 186,492 149,344
Activities in securities held-to-maturity:    
Purchases 0 (3,822)
Maturities, prepayments and calls 8,948 6,745
Increase in loans, net (2,738,112) (1,110,214)
Purchases of software, premises and equipment (18,663) (28,686)
Proceeds from sales of software, premises and equipment 0 52
Proceeds from sale of other real estate 5,130 3,117
Purchase of bank owned life insurance policies 0 (110,000)
Proceeds from bank owned life insurance settlements 1,690 217
Proceeds from Derivative Instrument, Investing Activities 35,680  
Payments for Derivative Instrument, Investing Activities   (37,982)
Purchase of trade name (1,000) 0
Increase in other investments (26,813) (31,352)
Net cash used in investing activities (3,256,712) (1,356,835)
Financing activities:    
Net increase in deposits 5,340,992 600,598
Net increase in securities sold under agreements to repurchase 68,199 49,428
Advances from Federal Home Loan Bank:    
Federal Home Loan Bank: Issuances, net of restructuring charges 762,472 2,222,500
Federal Home Loan Bank: Payments/maturities (1,037,518) (1,706,028)
Increase in other borrowings, net of issuance costs 56,568 0
Decrease in other borrowings (89,579) (21,152)
Principal payments of finance lease obligation (120) (111)
Issuance of preferred stock, net of issuance costs 217,632 0
Issuance of common stock pursuant to restricted stock unit agreement, net of shares withheld for taxes (2,488) 0
Exercise of common stock options, net of repurchase of restricted shares (2,280) (4,149)
Repurchase of common stock (50,790) (37,424)
Common stock dividends paid (24,820) (24,977)
Net cash provided by financing activities 5,238,268 1,078,685
Net increase (decrease) in cash, cash equivalents, and restricted cash 2,166,754 (94,105)
Cash, cash equivalents, and restricted cash, beginning of period 526,707 721,692
Cash, cash equivalents, and restricted cash, end of period 2,693,461 627,587
Commercial loans held for sale:    
Adjustments to reconcile net income to net cash provided by operating activities:    
Loans originated (180,238) (209,747)
Loans sold 182,844 206,214
Consumer loans held for sale:    
Adjustments to reconcile net income to net cash provided by operating activities:    
Loans originated (955,401) (617,164)
Loans sold $ 995,979 $ 592,244